Where does Dignity Health rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Dignity Health ranks #2,501 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Dignity Health hold?

Dignity Health holds 156 US utility patents granted between 2015 and 2025, spanning 53 technology areas.

What is Dignity Health's Innovation Score?

Dignity Health has an Innovation Score of 57.9 out of 100 (top 5% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Dignity Health focus on?

Dignity Health's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 77 patents, ranking #239 of 7,127 assignees active in that subclass. Grants appear in 53 CPC subclasses total.

Is Dignity Health's patent grant rate increasing or decreasing?

Dignity Health's recent grant velocity is +87% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Dignity Health's patents?

Dignity Health's patents average 15.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Dignity Health patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Dignity Health

USPTO PatentsView assignee record - 156 granted patents across 53 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Dignity ranks #2,501 of 49,997 tracked US assignees by granted-patent volume, with 156 patents across 53 technology areas.

#2,501
of 49,997 US assignees by volume: Top 5%
by Innovation Score (57.9/100): 15.0
avg claims per patent: +87%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R2501 · US Corporation #2,501 · 156 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MID 156 grants
TOP-DECILE #2,501/49,997
PHOTO-FINISH Applied Biosystems
CPC-WIDE A61B · 53 areas
INNOV-PAR 57.9/100
CLAIMS-RICH 15.0 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +87% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Applied Biosystems, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Dignity’s 57.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 17.5 pts (30%) Velocity 6.4 pts (11%) Breadth 25.0 pts (43%) Claim depth 9.0 pts (16%)

Qualcomm Incorporated · highest

85
Adient US · near

58
Dignity Health · this assignee

58
Dualitas · near

58
Nihon Kohden · near

58
American Sterilizer · near

58
3D Lighting… · lowest

7

What this shows Dignity's Innovation Score is 57.9/100 (top 5% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Dignity?

Each dot is one of Dignity’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Dignity’s own 15.0 claims/patent is at or below the 15.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Dignity vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How Dignity's grant cadence moved

Between 2020–2024, Dignity Health received 86 grants versus 46 in 2015–2019 (+87% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2020 at 19 grants and bottomed in 2015 at 4. Lead class A61B accounts for 49.4% of the portfolio across 53 subclasses. Volume neighbours: Axalta Coating Systems IP Co., LLC (#2,497) and National Applied Research Laboratories (#2,505).

Dignity's three-year grant acceleration

From 2019–2021 to 2022–2024, Dignity Health moved from 53 to 51 grants (0.96x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,293. See the growth leaderboard.

Axalta Coating Sy…

156
Applied Biosystems

156
B1 Institute OF I…

156
Cyberark Software

156
Khalifa Universit…

156
MS

156
National Chung Ch…

156
National Applied…

156
Dignity Health ◀

156

What this shows Dignity holds 156 patents at rank #2,501, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Dignity

By rank, the assignees closest to #2,501 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Dignity's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Dignity, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Dignity ranks #239 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (58 here).

Nihon Kohden Corporation 58 Adient US LLC 58 Dualitas Ltd 58 American Sterilizer Company 58

Similar claim depth

Nearest assignees by average claims per patent (15.0 here).

Signode Industrial Group LLC 15.0 avg Butamax Advanced Biofuels LLC 15.0 avg LG CNS Co., Ltd. 15.0 avg Gigaphoton Inc. 15.0 avg

Dignity's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

58 Top 5% higher than 95% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Dignity Health patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	4	2.6%
2016	7	4.5%
2017	8	5.1%
2018	9	5.8%
2019	18	11.5%
2020	19	12.2%
2021	16	10.3%
2022	15	9.6%
2023	19	12.2%
2024	17	10.9%
2025partial year	24	15.4%

Which technologies does Dignity Health patent most?

A61B - DIAGNOSIS; SURGERY; Identification 77

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 36

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 23

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 23

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 19

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 13

C12Y - Enzymes 11

G06F - Electric Digital Data Processing 10

Y02A - Technologies FOR Adaptation TO Climate Change 9

B21F - Working OR Processing OF Metal Wire 8

B21D - Working OR Processing OF Sheet Metal OR Metal Tubes, Rods OR Profiles Without Essentially Removing MATERIAL; Punching Metal 8

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 8

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 7

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 7

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 6

Top 15 of 53 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Dignity Health's patent record in context - here's where to go next.

Dignity Health's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 49.4% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #2,501 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Dignity Health against Axalta Coating Systems IP Co., LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 57.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.